Cargando…

Enteric nervous system abnormalities are present in human necrotizing enterocolitis: potential neurotransplantation therapy

INTRODUCTION: Intestinal dysmotility following human necrotizing enterocolitis suggests that the enteric nervous system is injured during the disease. We examined human intestinal specimens to characterize the enteric nervous system injury that occurs in necrotizing enterocolitis, and then used an a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yu, Yang, Jixin, Watkins, Daniel J, Boomer, Laura A, Matthews, Mika A, Su, Yanwei, Besner, Gail E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054965/
https://www.ncbi.nlm.nih.gov/pubmed/24423414
http://dx.doi.org/10.1186/scrt387
_version_ 1782320573989257216
author Zhou, Yu
Yang, Jixin
Watkins, Daniel J
Boomer, Laura A
Matthews, Mika A
Su, Yanwei
Besner, Gail E
author_facet Zhou, Yu
Yang, Jixin
Watkins, Daniel J
Boomer, Laura A
Matthews, Mika A
Su, Yanwei
Besner, Gail E
author_sort Zhou, Yu
collection PubMed
description INTRODUCTION: Intestinal dysmotility following human necrotizing enterocolitis suggests that the enteric nervous system is injured during the disease. We examined human intestinal specimens to characterize the enteric nervous system injury that occurs in necrotizing enterocolitis, and then used an animal model of experimental necrotizing enterocolitis to determine whether transplantation of neural stem cells can protect the enteric nervous system from injury. METHODS: Human intestinal specimens resected from patients with necrotizing enterocolitis (n = 18), from control patients with bowel atresia (n = 8), and from necrotizing enterocolitis and control patients undergoing stoma closure several months later (n = 14 and n = 6 respectively) were subjected to histologic examination, immunohistochemistry, and real-time reverse-transcription polymerase chain reaction to examine the myenteric plexus structure and neurotransmitter expression. In addition, experimental necrotizing enterocolitis was induced in newborn rat pups and neurotransplantation was performed by administration of fluorescently labeled neural stem cells, with subsequent visualization of transplanted cells and determination of intestinal integrity and intestinal motility. RESULTS: There was significant enteric nervous system damage with increased enteric nervous system apoptosis, and decreased neuronal nitric oxide synthase expression in myenteric ganglia from human intestine resected for necrotizing enterocolitis compared with control intestine. Structural and functional abnormalities persisted months later at the time of stoma closure. Similar abnormalities were identified in rat pups exposed to experimental necrotizing enterocolitis. Pups receiving neural stem cell transplantation had improved enteric nervous system and intestinal integrity, differentiation of transplanted neural stem cells into functional neurons, significantly improved intestinal transit, and significantly decreased mortality compared with control pups. CONCLUSIONS: Significant injury to the enteric nervous system occurs in both human and experimental necrotizing enterocolitis. Neural stem cell transplantation may represent a novel future therapy for patients with necrotizing enterocolitis.
format Online
Article
Text
id pubmed-4054965
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40549652014-06-13 Enteric nervous system abnormalities are present in human necrotizing enterocolitis: potential neurotransplantation therapy Zhou, Yu Yang, Jixin Watkins, Daniel J Boomer, Laura A Matthews, Mika A Su, Yanwei Besner, Gail E Stem Cell Res Ther Research INTRODUCTION: Intestinal dysmotility following human necrotizing enterocolitis suggests that the enteric nervous system is injured during the disease. We examined human intestinal specimens to characterize the enteric nervous system injury that occurs in necrotizing enterocolitis, and then used an animal model of experimental necrotizing enterocolitis to determine whether transplantation of neural stem cells can protect the enteric nervous system from injury. METHODS: Human intestinal specimens resected from patients with necrotizing enterocolitis (n = 18), from control patients with bowel atresia (n = 8), and from necrotizing enterocolitis and control patients undergoing stoma closure several months later (n = 14 and n = 6 respectively) were subjected to histologic examination, immunohistochemistry, and real-time reverse-transcription polymerase chain reaction to examine the myenteric plexus structure and neurotransmitter expression. In addition, experimental necrotizing enterocolitis was induced in newborn rat pups and neurotransplantation was performed by administration of fluorescently labeled neural stem cells, with subsequent visualization of transplanted cells and determination of intestinal integrity and intestinal motility. RESULTS: There was significant enteric nervous system damage with increased enteric nervous system apoptosis, and decreased neuronal nitric oxide synthase expression in myenteric ganglia from human intestine resected for necrotizing enterocolitis compared with control intestine. Structural and functional abnormalities persisted months later at the time of stoma closure. Similar abnormalities were identified in rat pups exposed to experimental necrotizing enterocolitis. Pups receiving neural stem cell transplantation had improved enteric nervous system and intestinal integrity, differentiation of transplanted neural stem cells into functional neurons, significantly improved intestinal transit, and significantly decreased mortality compared with control pups. CONCLUSIONS: Significant injury to the enteric nervous system occurs in both human and experimental necrotizing enterocolitis. Neural stem cell transplantation may represent a novel future therapy for patients with necrotizing enterocolitis. BioMed Central 2013-12-25 /pmc/articles/PMC4054965/ /pubmed/24423414 http://dx.doi.org/10.1186/scrt387 Text en Copyright © 2013 Zhou et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Zhou, Yu
Yang, Jixin
Watkins, Daniel J
Boomer, Laura A
Matthews, Mika A
Su, Yanwei
Besner, Gail E
Enteric nervous system abnormalities are present in human necrotizing enterocolitis: potential neurotransplantation therapy
title Enteric nervous system abnormalities are present in human necrotizing enterocolitis: potential neurotransplantation therapy
title_full Enteric nervous system abnormalities are present in human necrotizing enterocolitis: potential neurotransplantation therapy
title_fullStr Enteric nervous system abnormalities are present in human necrotizing enterocolitis: potential neurotransplantation therapy
title_full_unstemmed Enteric nervous system abnormalities are present in human necrotizing enterocolitis: potential neurotransplantation therapy
title_short Enteric nervous system abnormalities are present in human necrotizing enterocolitis: potential neurotransplantation therapy
title_sort enteric nervous system abnormalities are present in human necrotizing enterocolitis: potential neurotransplantation therapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054965/
https://www.ncbi.nlm.nih.gov/pubmed/24423414
http://dx.doi.org/10.1186/scrt387
work_keys_str_mv AT zhouyu entericnervoussystemabnormalitiesarepresentinhumannecrotizingenterocolitispotentialneurotransplantationtherapy
AT yangjixin entericnervoussystemabnormalitiesarepresentinhumannecrotizingenterocolitispotentialneurotransplantationtherapy
AT watkinsdanielj entericnervoussystemabnormalitiesarepresentinhumannecrotizingenterocolitispotentialneurotransplantationtherapy
AT boomerlauraa entericnervoussystemabnormalitiesarepresentinhumannecrotizingenterocolitispotentialneurotransplantationtherapy
AT matthewsmikaa entericnervoussystemabnormalitiesarepresentinhumannecrotizingenterocolitispotentialneurotransplantationtherapy
AT suyanwei entericnervoussystemabnormalitiesarepresentinhumannecrotizingenterocolitispotentialneurotransplantationtherapy
AT besnergaile entericnervoussystemabnormalitiesarepresentinhumannecrotizingenterocolitispotentialneurotransplantationtherapy